At the time of the April 28 announcement, Health Canada said it was reviewing eight other submissions for generic semaglutide from different companies and expected to make regulatory decisions on more of these submissions in the coming weeks and months
Last Published 04.01.2026 Effective Date: 04.01.2026 This policy addresses the use of somatostatin analogs, including Sandostatin (octreotide acetate), Sandostatin LAR (octreotide acetate LAR), Signifor (pasireotide diaspartate), Signifor LAR (pasireotide), and Somatuline Depot (lanreotide), and Lanreotide Injection
Every batch of Retatrutide 20mg is tested for purity and identity using industry-standard methods
Review on psyllium husk: nutritional, functional, health benefits, food industry applications, waste treatment, and potential negative effects